The Cancer SIGNAL
Welcome to The Cancer SIGNAL, a podcast presented by GRAIL.
On this monthly podcast, we explore topics relating to early cancer detection, including multi-cancer early detection testing, cancer genomics and risk, barriers to cancer screening, and much more.
Susanna Quinn is a cancer survivor, entrepreneur, writer and philanthropist. She was Founder and CEO of Veluxe, an on-demand fitness and beauty company, which she sold to Glamsquad.
Susanna started her career on Capitol Hill, working as a Research Assistant, Legislative Aide and Deputy Chief of Staff in the United States Congress. Prior to founding Veluxe, Susanna worked in real estate, as a freelance writer and as a consultant. Susanna has been featured in The Washington Post, Washingtonian, Washington Life, Baltimore Sun, Chicago Sun Times, Town and Country Magazine and other publications as a business, fashion and lifestyle expert and her writing has also appeared in The Washington Post, Huffington Post, The Washington Times, The Daily Beast, The Sunday Paper and Capitol File magazine. Susanna holds regular off the record salon media dinners for women journalists with members of the House and the Senate, the Cabinet and senior Administration officials on the topics of the day.
In her philanthropic work, Susanna is a sustaining board member of the Prevent Cancer Foundation and has chaired the Prevent Cancer Foundation gala for the last two years. She has chaired two National Portrait Gallery’s Portrait of a Nation galas, the Children’s Ball for the Children’s National Medical Center, the Share our Strength’s No Kid Hungry annual dinner and the Meridian Ball.
She lives in Washington DC with her son and daughter.
Episodes
Important safety information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “No Cancer Signal Detected” does not rule out cancer. A test result of “Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
For more information, please visit Galleri.com.